Skip to content

Medpace Holdings, Inc. MEDP Weighted Average Exercise Price of Outstanding Options

Weighted Average Exercise Price of Outstanding Options at other companies

Veeva Systems logo
Veeva SystemsVEEV
Medline, Inc.
 logo
Medline, Inc. MDLN
Guardant Health logo
Guardant HealthGH

Other financials

Income statement

See full
Revenue$706.6M+26.5%
Operating income$141.5M+24.6%
Net income$123.9M+8.1%
EPS (diluted)$4.28+16.6%

Balance sheet

See full
Cash & equivalents$652.7M+47.9%
Total debt$146.1M-2.8%
Total equity$598.3M+0.8%
Total assets$2.1B+12.2%

Cash flow

See full
Operating cash flow$151.8M+20.6%
CapEx$6.8M-31.8%
Free cash flow$145.0M+25.1%

Valuation

See full
Market cap$13.14B+46.8%
Enterprise value$12.64B+45.9%
P/E28.6×+7.0×
P/S4.9×+0.8×

Profitability

See full
Operating margin21%-0.1pp
Net margin17.2%-2.1pp
FCF margin26.5%+1.5pp

Returns & leverage

See full
Return on equity77.3%+11.4pp
Debt / equity0.2×0.0×
Current ratio0.8×+0.1×

Where this comes from

Reported directly by Medpace Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice.

The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medpace Holdings, Inc.'s weighted average exercise price of outstanding options.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Medpace Holdings, Inc.'s weighted average exercise price of outstanding options?
Medpace Holdings, Inc. (MEDP) reported weighted average exercise price of outstanding options of $224.33 in Q1 2026.
How has Medpace Holdings, Inc.'s weighted average exercise price of outstanding options changed year-over-year?
Medpace Holdings, Inc.'s weighted average exercise price of outstanding options increased by 19.6% year-over-year, from $187.57 to $224.33.
What is the long-term trend for Medpace Holdings, Inc.'s weighted average exercise price of outstanding options?
Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s weighted average exercise price of outstanding options has grown at a 32.6% compound annual growth rate (CAGR), from $68.39 to $211.29.